Table 1. Current indications for surgery in asymptomatic hyperparathyroidism and comparison with previous ones.
Measurement | 2002 | 2008 | 2013 |
---|---|---|---|
Serum calcium
(>upper limit of normal) |
1.0 mg/dL (0.25 mmol/L) | 1.0 mg/dL (0.25 mmol/L) | 1.0 mg/dL (0.25 mmol/L) |
Skeletal | BMD by DXA: T-score < −2.5
at any site |
BMD by DXA: T-score < −2.5
at any site |
A. BMD by DXA: T-score < −2.5 at lumbar spine,
total hip, femoral neck, or distal 1/3 radius B. Vertebral fracture by X-ray, CT, magnetic resonance imaging, vertebral fracture assessment |
Renal | A. eGFR reduced by >30%
from expected B. 24-hour urine for calcium >400 mg/day (>10 mmol/day) |
A. eGFR < 60 cc/minute
B. 24-hour urine for calcium not recommended |
A. Creatinine clearance < 60 cc/minute
B. 24-hour urine for calcium >400 mg/day (>10 mmol/day) and increased stone risk by biochemical stone risk analysis C. Presence of nephrolithiasis or nephrocalcinosis by X-ray, ultrasound, or CT |
Age, years | <50 | <50 | <50 |
BMD, bone mineral density; CT, computed tomography; DXA, dual-energy X-ray absorptiometry; eGFR, estimated glomerular filtration rate 48.